Overview: Apolipoprotein B TestIntroduction: The Apolipoprotein B Test measures apolipoprotein B (Apo B) levels, a protein linked to cholesterol, to assess heart disease risk, which may cause chest pain or shortness of breath. Following 2023 AHA guidelines, it uses an immunoassay for high sensitivity, aiding in cardiovascular screening. This test is critical for guiding risk assessment, preventive strategies, and improving outcomes in biochemistry for patients with suspected cardiovascular conditions.
Other Names: Apo B Assay, Cholesterol Protein Test.
FDA Status: Laboratory-developed test (LDT), meeting biochemistry standards for diagnostic accuracy.
Historical Milestone: Apo B testing began in the 1980s with lipid profiling. Immunoassays emerged in the 1990s, and by the 2010s, high-sensitivity assays improved heart disease risk assessment.
Purpose: Assesses heart disease risk, guides preventive measures, and monitors lipid metabolism in patients with chest pain or shortness of breath.
Test Parameters: 1. Apolipoprotein B
Pretest Condition: Fasting for 10-12 hours required to stabilize lipid levels. Collect serum or plasma after overnight fasting. Report symptoms like chest pain or shortness of breath, and list medications like statins.
Specimen: 2-5 mL serum (serum separator tube, SST) or 2-4 mL plasma (EDTA). Centrifuge within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document cardiovascular symptoms, family history of heart disease, or lipid disorders. Include current medications, especially statins or fibrates.
Consent: Written consent required, detailing the tests purpose, implications for heart disease risk, and potential need for lipid-lowering therapy.
Procedural Considerations: Uses an immunoassay to measure Apo B levels. Results are available in 1-2 days, enabling rapid clinical decisions. Performed in laboratories with strict quality controls.
Factors Affecting Result Accuracy: Non-fasting samples or lipid-lowering medications may alter results. Hemolysis or improper storage can degrade samples.
Clinical Significance: Elevated Apo B levels indicate increased heart disease risk, prompting lifestyle changes or statin therapy. Normal levels support ongoing monitoring.
Specialist Consultation: Consult a cardiologist for result interpretation. A lipidologist referral is advised for complex dyslipidemia cases.
Additional Supporting Tests: Lipid profile, LDL-C test, or hs-CRP to assess cardiovascular risk comprehensively.
Test Limitations: Apo B levels may not fully predict heart disease risk without clinical correlation. Results require integration with other lipid markers.
References: AHA Lipid Guidelines, 2023; Circulation, Grundy SM, 2022.
